Drug Pipeline

Imetelstat Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
3
Recruiting
1
Phase 3
5
Top Sponsors
Active Studies by Phase
Phase 2/3
1
Phase 2
2
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT02598661 Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic… Myelodysplastic Syndromes Active, Not Recruiting
Phase 2
NCT07549451 Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms Phase II Not Yet Recruiting
NCT05583552 Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based… Myelodysplastic Syndromes Active, Not Recruiting
Phase 1
NCT05371964 A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity… Myelofibrosis Recruiting
NCT06247787 A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and… Recurrent Childhood Acute Myeloid Leukemia Recruiting
NCT07320235 Imetelstat Combinations in Relapsed AML Relapsed Acute Myeloid Leukemia Recruiting
Sponsors Running Imetelstat Trials
Geron Corporation (2) GCP-Service International West GmbH (1) Children's Oncology Group (1) Douglas Tremblay (1) M.D. Anderson Cancer Center (1)
Disease Areas
Myelodysplastic Syndromes (MDS) (4) Leukemia (3) Acute Myeloid Leukemia (AML) (3) Myelofibrosis (2)
Get alerts when Imetelstat trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free